Drug-labels.com

Ropivacaine Hydrochloride Injection, USP (Fresenius Kabi Canada, 7.5 mg): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Current status: Cancelled Pre Market
Strength:
7.5 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - Ropivacaine Hydrochloride Injection, USP (Fresenius Kabi Canada, 7.5 mg)

What is Ropivacaine Hydrochloride Injection, USP used for?

Ropivacaine Hydrochloride Injection, USP is used as an anesthetic and for pain relief. It can be used:

  • to anesthetize the area of the body where surgery is performed;
  • to provide pain relief in labour and after surgery or acute injury.

Ropivacaine Hydrochloride Injection, USP is not for use in children under 18 years of age.

How does Ropivacaine Hydrochloride Injection, USP work?

Ropivacaine Hydrochloride Injection, USP temporarily prevents the nerves in the injected area from transmitting feelings of pain, heat or cold. You may still feel pressure and touch. In many cases the nerves to the muscles in the area will also be blocked. This may cause temporary weakness or paralysis.

The duration of pain relief depends on the dose and how it is given.

What are the ingredients in Ropivacaine Hydrochloride Injection, USP?

Medicinal ingredient: Ropivacaine hydrochloride 2 mg / mL, 5 mg / mL, 7.5 mg / mL and 10 mg / mL.

Non-medicinal ingredients: sodium chloride, hydrochloric acid and/or sodium hydroxide and water for injection.

Ropivacaine Hydrochloride Injection, USP comes in the following dosage forms:

Ropivacaine Hydrochloride Injection, USP 2 mg / mL for epidural infusion is available in 100 and 200 mL freeflex® infusion bags.

Ropivacaine Hydrochloride Injection, USP 2 mg / mL, 7.5 mg / mL and 10 mg / mL are available in 10 mL and 20 mL ampoules. The 5 mg/mL is available in 10 mL ampoules only.

Do not use Ropivacaine Hydrochloride Injection, USP if:

Ropivacaine Hydrochloride Injection, USP should not be used in patients who:

  • are allergic to ropivacaine, any other “-caine” type anesthetics, or any of the non-medicinal ingredients in the product

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take Ropivacaine Hydrochloride Injection, USP. Talk about any health conditions or problems you may have, including:

  • about all health problems you have now or have had in the past;
  • about other medicines you take, including ones you can buy without a prescription;
  • if you are taking drugs used to treat irregular heart activity (anti-arrhythmics, such as
  • amiodarone);
  • if you have ever had a bad, unusual allergic reaction to ropivacaine or any other medicines ending with “-caine”;
  • if you have a heart, liver or kidney disease, since the dose of Ropivacaine Hydrochloride Injection, USP may have to be adjusted;
  • if you are pregnant, plan to become pregnant or are breastfeeding;

  • if you have been diagnosed with porphyria, a rare hereditary disorder.

Other warnings you should know about:

  • Ropivacaine Hydrochloride Injection, USP could cause irreversible joint damage if it is used to manage your pain after joint surgery.
  • Ropivacaine Hydrochloride Injection, USP may temporarily interfere with your ability to drive or operate tools or machinery.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

The following may interact with Ropivacaine Hydrochloride Injection, USP:

  • drugs that treat heart rhythm problems (e.g. mexiletine, amiodarone);
  • other local anesthetics;
  • sedative drugs;
  • if using Ropivacaine Hydrochloride Injection, USP for a long time:

    • fluvoxamine or imipramine, used to treat depression
    • enoxacin, an antibiotic
    • theophylline, used to treat lung diseases

Usage of some medicines at the same time as Ropivacaine Hydrochloride Injection, USP may increase the risk of serious side effects.

How to take Ropivacaine Hydrochloride Injection, USP:

Usual dose:

Ropivacaine Hydrochloride Injection, USP should be administered by a doctor. It can be administered by an anesthesia professional under the supervision of a doctor.

The dose to be given is decided by the doctor, based on the clinical need and your physical condition.

Overdose:

You can have serious side effects from getting too much Ropivacaine Hydrochloride Injection, USP. You may need treatment to deal with the side effects from the overdose. The doctor treating you is trained to deal with these situations. The first signs of being given too much ropivacaine hydrochloride injection are usually as follows:

  • Feeling dizzy or light-headed.
  • Numbness of the lips and around the mouth.
  • Numbness of the tongue.
  • Hearing problems.
  • Tingling in the ears.
  • Problems with your sight (vision).

More serious side effects from being given too much Ropivacaine Hydrochloride Injection, USP include:

  • problems with speech
  • twitching muscles
  • tremors
  • trembling
  • seizures
  • loss of consciousness
  • change in heart rhythm
  • heart attack
  • decrease in blood pressure

To reduce the risk of serious side effects, your doctor will stop giving you Ropivacaine Hydrochloride Injection, USP as soon as these signs appear.

If you think you have taken too much ROPIVACAINE HYDROCHLORIDE INJECTION, USP, contact your healthcare professional, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

What are possible side effects from using Ropivacaine Hydrochloride Injection, USP?

These are not all the possible side effects you may feel when taking Ropivacaine Hydrochloride Injection, USP. If you experience any side effects not listed here, contact your healthcare professional.

Medicines affect different people in different ways. Just because side effects have occurred in some patients, does not mean that you will get them.

Tell your doctor as soon as possible if you do not feel well during treatment with Ropivacaine Hydrochloride Injection, USP.

Possible side effects include:

Numbness, due to nerve irritation caused by the needle or the injection. This does not usually last for long.

Possible side effects seen with other local anesthetics which might also be caused by Ropivacaine Hydrochloride Injection, USP include:

Damaged nerves. Rarely (affecting less than 1 in 1000 people), this may cause permanent problems.

If too much Ropivacaine Hydrochloride Injection, USP is given into the spinal fluid, the whole body may become numbed (anesthetized).

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases

VERY COMMON

Low blood pressure: feeling dizzy or light-headed

√
Nausea√

COMMON

Pins and needles

√
Feeling dizzy√
Headache√
Slow or fast heart beat√
High blood pressure√
Vomiting√
Difficulty in passing urine√
High temperature (fever) or stiffness (rigor)√
Back Pain√

UNCOMMON

Anxiety

√
Decreased sensitivity or feeling in the skin√
Fainting√
Difficulty breathing√
Low body temperature√

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
Some symptoms can happen if the injection was given into a blood vessel by mistake, or if you have been given too much Ropivacaine Hydrochloride Injection, USP: seizures, feeling dizzy or light-headed, numbness of the lips and around the mouth, numbness of the tongue, hearing problems, problems with sight, problems with speech, stiff muscles, and trembling√
Numbness√
Nerve Damage√

RARE

Heart attack

√
Severe allergic reaction (anaphylaxis): sudden onset of rash, itching or lumpy rash (hives); swelling of the face, lips, tongue or other parts of the body; and shortness of breath, wheezing or difficulty breathing.√
Uneven heart beat√

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

Your doctor or the hospital will normally store Ropivacaine Hydrochloride Injection, USP. The staff is responsible for storing, dispensing and disposing of Ropivacaine Hydrochloride Injection, USP in the correct way.

Store at 15 °C to 30 °C. Do not freeze. Do not autoclave.

Ropivacaine Hydrochloride Injection, USP will be kept out of reach and sight of children.

If you want more information about Ropivacaine Hydrochloride Injection, USP:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient

    • Medication Information by visiting the Health Canada website (https://health-products.canada.ca/dpd-bdpp/index-eng.jsp); Fresenius Kabi Canada’s website (http://www.fresenius-kabi.com/en-ca/), or by calling 1-877-821-7724.

Fresenius Kabi Canada Ltd.

165 Galaxy Blvd, Suite 100

Toronto, ON M9W 0C8

Last revised: October 7, 2019

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02439395

Revision date stated in the text: October 7, 2019

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Ropivacaine Hydrochloride Injection, USP (Fresenius Kabi Canada, 7.5 mg)

DIN 02439395
Schedule(s) ETHICAL
Active ingredient(s) Ropivacaine hydrochloride 7.5 MG
Dosage form(s) Solution
Route(s) of administration Nerve Block, Epidural
Drug class (WHO ATC)
  1. N Nervous system drugs
    1. N01 Anesthetics
      1. N01B Local anesthetics
        1. N01BB Amide local anesthetics
          1. N01BB09 Ropivacaine
Company FRESENIUS KABI CANADA LTD
Current status Cancelled Pre Market
Current status date March 10, 2023

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.